(2R)-2-[[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-pyridinyl]-(2,2,2-trifluoroethyl)amino]propanamide
C17H15ClF3N5O — CID 71549389
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-[[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-pyridinyl]-(2,2,2-trifluoroethyl)amino]propanamide
(2R)-2-[[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-pyridinyl]-(2,2,2-trifluoroethyl)amino]propanamide (PubChem CID 71549389) has the molecular formula C17H15ClF3N5O and a molecular weight of 397.79 g/mol. Its IUPAC name is (2R)-2-[[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-pyridinyl]-(2,2,2-trifluoroethyl)amino]propanamide.
Molecular Properties
| Compound Name | (2R)-2-[[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-pyridinyl]-(2,2,2-trifluoroethyl)amino]propanamide |
|---|---|
| PubChem CID | 71549389 |
| Molecular Formula | C17H15ClF3N5O |
| Molecular Weight | 397.79 g/mol |
| Exact Mass | 397.09 |
| IUPAC Name | (2R)-2-[[5-(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)-3-pyridinyl]-(2,2,2-trifluoroethyl)amino]propanamide |
| SMILES | C[C@H](C(N)=O)N(CC(F)(F)F)c1cncc(-c2c[nH]c3ncc(Cl)cc23)c1 |
| InChI | InChI=1S/C17H15ClF3N5O/c1-9(15(22)27)26(8-17(19,20)21)12-2-10(4-23-6-12)14-7-25-16-13(14)3-11(18)5-24-16/h2-7,9H,8H2,1H3,(H2,22,27)(H,24,25)/t9-/m1/s1 |
| InChIKey | CKVZRPDGHLWRMH-SECBINFHSA-N |
| XLogP | 3.52 |
| TPSA | 87.90 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 397.79 |
| LogP ≤ 5 | 3.52 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71549389 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.